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INTRODUCTION AND BACKGROUND:
BENEFITS OF SELF-MEASURE
Self-Measure (SM) of heart rate variabil-
ity (HRV) may provide a novel tool to
monitor and tomanage atrial arrhythmias.
In the present article, I report my expe-
rience monitoring HRV and arrhythmias
simultaneously, and how I discovered that
acute episodes of high intensity interval
exercise (HIIE) terminated atrial arrhyth-
mias. I propose that SM of HRV may help
identify therapies that retard the progres-
sion of arrhythmia toward atrial fibrilla-
tion (AFIB) and stroke with aging, starting
at ages 45–55 years of age (Feinberg et al.,
1995).
MEDICAL HISTORY
I am an 85 year old male. In 2009, I
had the MAZE procedure during aortic
valve replacement surgery to treat AFIB.
The MAZE procedure was not effective,
failing to prevent AFIB or to reduce the
number of premature atrial contractions
(PACs). Therefore, I recently underwent
cryoablation of the left and right atrium to
control AFIB and PACs, respectively. I am
pleased to report that now, 3 months later,
the cryoablation procedures have reduced
the number of PACs and have eliminated
AFIB. These procedures have given me
a stable, predictable heart rhythm with
the opportunity for an improved life. The
residual premature atrial arrhythmias that
occur in the evening have been managed
successfully. I use 80mg Sotalol during the
day and 40mg at night in combination
with HIIE (Meyer et al., 2013) to convert
atrial arrhythmias to a sinus rhythm when
needed in the evening.
SELF-MONITORING OF MY HRV
I began monitoring my HRV September
2008 using commonly available sensors. I
measure the maximum sustainable reso-
nant respiratory periodic HRV in bpm or
RR Interval (RR-I in ms) for two or three
nearly equal amplitude periods of HRV
both at rest and during HIIE. Over the
ensuing years, I found that arrhythmias
disturbed my SM HRV as these arrhyth-
mias increased non- monotonically to
AFIB and stroke despite treatment with
80mg of Sotolol, a beta-adrenergic recep-
tor blocker administered twice a day. I per-
sonally confirm that increasingly frequent
premature atrial complexes were associ-
ated with AFIB and adverse cardiovascular
events (Chong et al., 2012).
SM led to a beneficial ablation of the
right atrial for a dramatic reduction in the
number of PACs, followed by left atrial
ablation for AF. My initial cardiology con-
sultation was less than favorable as this
cardiologist would not look at my SM data
and refused my request for ablation treat-
ment. However, I was fortunate to find
a second cardiologist who examined my
HRV, HR, RR, ECG data, and agreed with
my interpretation of these data, ultimately
performing the ablations procedures that
restored my cardiac rhythm.
I observed an abnormal HRV pat-
tern after seizure. My HRV dropped from
the typical 1.5–0.5 bpm, the wave form
changed from sinusoidal to chaotic, and
the HRV was not responsive to respira-
tion. I also noticed that my HRV some-
times changes immediately after an ectopic
pulse. These measures demonstrate the
significant sensitivity and timeliness of
the SM approach. These observations are
coincident with the incidents and were
detected at home rather than having to
reproduce an irregularity on schedule at
the doctor’s office.
SM, therefore, is ideally suited to iden-
tify arrhythmias, (e.g., premature atrial,
PAC; ventricular, PVC; or junctional, PJC,
activations), and ECG anomalies, so that
an appropriate medical facility and per-
sonnel can be selected to obtain optimal
treatment. Early identification of patients
at high risk of AFIB would enable more
aggressive primary prevention and tar-
geted intervention (Chong et al., 2012).
In addition, SM of HRV could be used to
evaluate the efficacy of a therapeutic inter-
vention, thereby allowing the physician
and patient to work together to find the
optimal therapy, an example of “person-
alized medicine.” HRV SM could be used
to determine the efficacy of exercise, reso-
nant breathing, or medications to address
non-lethal arrhythmias, enabling tailored
treatment for each patient.
SM FOR MANAGEMENT OF
ARRHYTHMIA
Frequent PACs provide an example of
a relatively benign arrhythmia that can
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become more serious with aging, since
frequent premature atrial complexes pre-
dict new occurrences of atrial fibrillation
and adverse cardiovascular events (Chong
et al., 2012). One potential use of SM is
PAC quantification in order to evaluate an
individual’s risk. Over the past decades, a
vast amount of evidence has shown that
almost any form of sustained or repet-
itive type of supraventricular arrhyth-
mias including supraventricular ectopic
beats can provoke myocardial dysfunction
(Simantirakis et al., 2012). It has been
known since 2006 that progressive aging
of the heart is broadly associated with an
increasing incidence of arrhythmias and
disorders of the normal origin of the heart-
beat (Jones, 2006). I, therefore, recom-
mend that individuals in their late 50’s or
early 60’s personally evaluate their ECG
for abnormalities and their RR-I for obvi-
ous arrhythmias or use the CV Risk (next
paragraph) as a guide which varies from a
PAC period of 14.5min to 6 s. Otherwise,
clinically significant arrhythmias may be
present for months or years, resulting
in myocardial remodeling (Simantirakis
et al., 2012).
PREMATURE ATRIAL COMPLEXES AND
CV RISK
Two studies found that a high premature
pulse rate increases the risk for adverse
cardiovascular events: Study (1) One PAC
or more every 14.5min, i.e., PACs >100
beats/day lowered the survival rate for
428 patients (without AF or structural
heart disease) after 6.8 years 11%, when
patients had frequent PACs (Chong et al.,
2012). Study (2) Sixty Four participants
in 14 years that initially had 10 PAC or
more every minute had 34 % combined
CVD, CHD, HF, Stroke deaths while 7628
healthy participants without PACs had 7.8
% deaths for the same causes (Inohara
et al., 2013).
SM OF HRV TO DETECT MY PACS
Recently, it was reported that a single ses-
sion of HIIE improved the autonomic pro-
file of CHF patients, leading to significant
reductions of HR and arrhythmic events in
a 24-h post training period (Guiraud et al.,
2013). Thus, my experience with exercise
is consistent with these findings, although
I appear to have achieved satisfactory
rhythm control more quickly than was
reported. I have experienced many con-
versions that occurred during the first half
of the HIIE period. However, there were
two exercise sessions when a full, steady
state conversion did not occur until 20min
after the exercise was complete. These two
sessions were both conducted after the
arrhythmia rate was high and later in the
evening than usual. Nonetheless, the pro-
cess is reliable, conversion having always
been achieved, and almost always during
the exercise period.
I typically experience two types of
residual arrhythmia, one in the evening
about 8:00 p.m. and one that initiates at
1 to 2:00 a.m. The rhythm patterns are
different and recognizable. The 8:00 p.m.
arrhythmias consists of a combination
of single, double, and triple premature
pulses along with sinus rhythm. The
FIGURE 1 | Conversion of arrhythmia with high intensity interval exercise (HIIE). (A–C) ordered
from top of page to bottom. Scales are common: RR Interval (s) 0.6–1.6 s, Time (h:min:s) is 0 to
0:1:40 s. To convert RR-I in milliseconds to heart rate (HR), divide 60,000 by RR, i.e., 60,000/RR=HR,
e.g., 60,000/600= 100bpm HR. (A) Conversion essentially complete. Recorded 5min after exercise.
HIIE starts after a 5min warm up at 2.7mph followed by 15 cycles of 1min @ 3.7mph and 1min of
rest for a total of 15min of intense exercise @ 3.7mph. (B) Arrhythmia recorded just prior to warm-up
for HIIE. Arrhythmia composed of one PVC, a large number of multifocal premature contractions, and
only 3 pulses joined along the typical sinus HRV at rest, and it takes about 13 pulses or 10 s to fully
define oneHRVwave or at least one half wave in 5 s. (HRV could not bemeasured in this case because
there were too many PACs). Most of the arrhythmias fall within the following range: RR 0.65–1.0ms,
corresponding to a HR 60–92 bpm. (C) This is the cardiac recovery response during a 1min rest period
between HIIE intervals. This follows the 10th of 15 HIIE cycles after a 5min warm up, extending the
rest period from 1min to 1.40 s for recording purposes. It takes 13 pulses typically to measure one
HRV wave form in 10 s. With 13 pulses in 10 s, the SDNN can be calculated manually with an RR-I
array of numbers. See Supplement. Results: 1st of 7 periods: HRV 2.8 bpm and Standard deviation of
normal to normal beats (SDNN) 13ms. Last of 7 periods: HRV 1.97 bpm and SDNN 10.9ms.
2:00 a.m. rhythm rate varies the most:
88 bpm premature pulses mixed with a
junctional escape rhythm bradycardia at
35 bpm and sinus rhythm @ 60 bpm.
Incidentally, the 2:00 a.m. rhythm converts
with the least exercise energy, e.g., running
in place for a minute, but is also the most
inconvenient since the conversion takes
place in the middle of the night.
CONVERSION OF ARRHYTHMIA:
EVENING-8 p.m., EARLY
MORNING-1:00 a.m.
The evening, 8:00 p.m., conversion of
arrhythmia is the most dramatic and per-
haps the most practical conversion as
compared to the nighttime opportuni-
ties. The results of the evening conversion
are shown in Figure 1. The evening
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conversion remains in sinus rhythm until
about 2:00 a.m. the next morning when
the lack of conversion seems to wake me
without symptoms; that is, at least symp-
toms that I am aware of.
Even when dysrhythmic pulses occur
in rapid sequence with few regular pulses,
the conversion to sinus rhythm usually
occurs before the HIIE is complete, i.e.,
only 15min of cumulative intense exercise.
The arrhythmia occurs regularly bet-
ween 1 and 3 a.m. On May 26th at
2:39 a.m. conversion was achieved in 1min
by trotting in place. Fortunately, sleep
follows conversion quickly. The arrhyth-
mia is probably present again sometime
after conversion but these arrhythmias are
always self-terminating in a little less than
an hour after rising in the morning. Most
incidents of arrhythmia occur at night,
not during the day. I suspect that being
horizontal a long time will also produce
arrhythmia, but I have not confirmed this
impression.
On one occasion on August 23rd, 2013,
I was able to convert paroxysmal atrial
tachycardia of 125 bpm. I applied intermit-
tent experimental variations of the HIIE
protocol and watched the regular 125 bpm
rhythm first became irregular and then
change from irregular to regular sinus in
1 h and 27min. The total exercise period
was probably less than 30min. This SM
result was encouraging.
Thus, as a result of using SM, I can
confirm that Sotalol, HIIE, and paced
breathing with a 10 s period manage my
arrhythmia, and reduce my stress. By ter-
minating these arrhythmias, I may also
reduce irritation of the heart tissue, and
perhaps extend the long-term outcome of
the catheter ablation of AFIB (Ganesan
et al., 2013).
SM OF ECG ABNORMALITIES
While using specific ECG abnormalities
to suggest stroke risk may not be ready for
prime time (Agarwal and Soliman, 2013),
SMof the ECG could soon provide detailed
insight for the individual. There are a num-
berofpublishedECGabnormalities thatare
associated with an increased risk for stoke
that an individual could use as part of their
self-monitoring. Potential candidatemark-
ers for SM include: QRS/QT prolongation
(Agarwal and Soliman, 2013), and frontal
planeQRS-Tangle(AroandHuikuri,2013).
SENSORS, LEADS, AND DISPLAYS:
HRV, HR, RR, ECG
I often do SM with a 3 tier simultaneous,
hybrid monitoring system that provides:
(1) An immediate narrowband, real-time
HRV waveform that is or is not consis-
tent with respiration, defines normal or
abnormal HR or HRV and is EMwave
(www.heartmath.com) PC displayed. The
EM wave is a narrow bandwidth sensor,
being designed for HRV coherence in bpm
so neither the amplitude nor timing of a
PAC is correct. However, the evaluation
is immediate. (2) The Wahoo HR mon-
itor, chest or finger HR sensor displays
real time RR-I numbers one at a time on
the iPod HRV Tracker application. Thus,
I can count how many regular pulses are
displayed between premature pulses and
thereby stratify risk and decide what action
should be taken if there are too few nor-
mal pulses. The RR-I file is being stored
during this time and then exported to
Kubios (Tarvainen et al., 2013) for analysis.
(3) The AliveCor.com ECG, is also being
recorded and then evaluated for both pre-
mature and junctional rhythms. Recorded
RR-I is evaluated with Kubios (Tarvainen
et al., 2013) software for both arrhyth-
mia and HRV bpm and SDNN-ms. Kubios
RR graphics is used to find the PAC/PVC
locations on the ECG.
When I have confidence that the ECG
has identified the arrhythmia, I indepen-
dently utilize the real time readout of the
RR numbers on my iPod to count how
many normal pulses I have between pre-
mature pulses, confirm that number on a
Notepad table, and then fully analyze with
Kubios. This number is my most important
SM variable I use on a day to day basis;
however, I always keep the ECG in mind.
Two of the three sensors are wireless
and hand held and the PC is clip-wired
to my ear, so it takes less than a 60 s to
hook-up and start a recording.
CONCLUSION
I have successfully used HRV SM to
discover ECG abnormalities, to detect
arrhythmias, and then to use this informa-
tion to convert arrhythmias to an accept-
able level of irregular heart rate with exer-
cise and/or medication. SM can be used to
monitor and to manage atrial arrhythmias
and could thereby reduce a susceptible
individual’s AFIB and Stroke risk.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this arti-
cle can be found online at: http://www.
frontiersin.org/journal/10.3389/fphys.
2014.00251/full
SUPPLEMENT Figure 1 | (C) HR and HRV
exponential recovery from HIIE exercise:
(Supplement, see expanded graphics). This
details the recovery response beginning in
about 32 s which coincides with the leading
edge of the 1st of 7 waves. The Supplement
presents this data graphically, concentrating
the display on the HRV recovery waves one
through seven. The HRV magnitude
diminishes with time dramatically during this
1.0min period.
First of 7 830 to 865ms, HRV 2.8 bpm
RR-I periods: 72.3 to 69.5 bpm SDNN 13
Last of 7 840 to 864ms, HRV 1.97 bpm,
RR-I periods: 71.4 to 69.48 bpm SDNN 10.9
Resting-HR: HRV 1.5 bpm,
SDNN 7.7
I have provided access to the digital RR-I
files for Figure 1 as well as the ECG’s for
the same period in the Supplement so that
the reader may conduct their own analysis.
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